Viewing nowSelcalcon Tablets (Polycarbophil Calcium)
Calcium Polycarbophil 625mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

MFDS item code 201601684 · Approved 2016.03.30 · Insurance code 693902140
Relief of symptoms of chronic constipation and diarrhea (Irritable Bowel Syndrome, etc.)
This medication is used to assist in the treatment of chronic constipation and nonspecific diarrhea, as well as constipation and diarrhea in irritable bowel syndrome.
As Polycarbophil Calcium, 1,250 mg should be taken orally once a day 1 to 4 times. The recommended initial dosage is 1,250 to 2,500 mg per day, with a maximum dose of 5,000 mg per day. It should not be taken just before bedtime, and a minimum of 1 hour should pass after digestion before sleeping.
Children aged 6 to 12 years should take Polycarbophil Calcium at a dose of 625 mg once orally 1 to 3 times a day. For children under 6 years, consult a physician.
This medication should not be used by anyone who is allergic to this drug or its components. It is also unsafe to administer to patients with unexplained rectal bleeding or those in severe dehydration. It should not be used in patients at risk of drug reflux, such as those with conditions that make swallowing difficult or those who must remain lying down. In cases of impaired bowel function or acute abdominal conditions, it should be avoided in patients with bowel obstruction or strictures, as it may worsen symptoms. Patients with hypercalcemia or renal stones, as well as those with severe renal failure, should not take this medication. Patients with severe abdominal pain, nausea, or vomiting also require caution. Patients who need to limit calcium intake or who are taking active forms of vitamin D should use this drug carefully due to the risk of hypercalcemia. Those taking cardiac glycosides should be aware that this drug may enhance the effects of cardiac glycosides and provoke arrhythmias. Patients with low stomach acid production or those who have had gastric resection may experience reduced effectiveness of this medication. Patients undergoing dialysis or those with mild renal failure should use this drug cautiously due to the risk of tissue calcification. It should be swallowed with plenty of water; taking it without water may pose risks of choking or obstruction in the throat or esophagus. If chest pain, vomiting, difficulty swallowing, or shortness of breath occurs, stop taking the medication immediately and consult a physician. This medication is intended for symptomatic relief; if symptoms do not improve after 7 days of use, consult a physician. Long-term use may lead to adverse reactions, so regular observation is necessary. When taken with other medications, it may affect absorption, so it is recommended to take it at least 2 hours apart. Caution is advised, especially when combined with certain antibiotics or active forms of vitamin D due to the risk of hypercalcemia. Women who are pregnant or may become pregnant should use this drug only when the benefits outweigh the risks, according to a physician's judgment. Safety in children has not been established, so caution is necessary for use. Elderly individuals are at higher risk for decreased kidney function and hypercalcemia and may require dose adjustments. This medication should be stored out of reach of children, in its original container, in a dry place at room temperature.
Bowel obstruction, hypercalcemia, hives, severe swelling, chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, skin peeling, pain in oral/ocular mucosa, wheezing or difficulty in breathing, asthma attacks, respiratory abnormalities accompanied by cough and fever, yellowing of the skin or eyes, significant fatigue, sudden and severe headaches, thunderclap headaches, seizures, confusion, visual disturbances, loss of consciousness
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent air exposure, at room temperature between 1 degrees and 30 degrees Celsius. Proper storage can help maintain the medication's effectiveness and prevent degradation.
White oval film-coated tablets
30 tablets/bottle, 500 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCalcium Polycarbophil 625mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Calcium Polycarbophil 625mg
Tablet · Prescription medication
Myungmoon Pharmaceutical Co., Ltd.

Calcium Polycarbophil 625mg
Tablet · Prescription medication
Geonil Pharmaceutical Co., Ltd.

Calcium Polycarbophil 625mg
Tablet · Prescription medication
Genupharm Co., Ltd.

Calcium Polycarbophil 625mg
Tablet · Prescription medication
Il Yang Pharmaceutical Co., Ltd.

Calcium Polycarbophil 625mg
Tablet · Prescription medication
Ajou Pharmaceutical Co., Ltd.

Calcium Polycarbophil 625mg
Tablet · Prescription medication
Heeon Pharmaceutical Co., Ltd.

Calcium Polycarbophil 625mg
Tablet · Prescription medication
Eden Pharma Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.